PAD

VentureMed Group Receives European Medical Device Regulation (MDR) Certification for FLEX Vessel Prep™ System

Retrieved on: 
Wednesday, September 6, 2023
Medical device, CE, Medical Devices Directive, CE marking, PAD, FLEX, Moyamoya disease, Quality, Certification, MDR, Patient, European Economic Area, Patient safety

MINNEAPOLIS, Sept. 6, 2023 /PRNewswire/ -- VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced today that the company is an early recipient of MDR certification.

Key Points: 
  • MINNEAPOLIS, Sept. 6, 2023 /PRNewswire/ -- VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced today that the company is an early recipient of MDR certification.
  • Gaining MDR certification ensures the FLEX device is in alignment with described requirements and conformity assessment procedures that must be met before medical devices are introduced into the European Economic Area.
  • "CE Mark under these new requirements is more stringent than the CE Mark under the Medical Device Directive and is focused on quality as well as patient safety.
  • "MDR certification demonstrates our commitment to quality and will enable continued commercial expansion of the FLEX Vessel Prep System into the CE marked geographies."

VentureMed Group Receives European Medical Device Regulation (MDR) Certification for FLEX Vessel Prep™ System

Retrieved on: 
Wednesday, September 6, 2023
Medical device, CE, Medical Devices Directive, CE marking, PAD, FLEX, Moyamoya disease, Quality, Certification, MDR, Patient, European Economic Area, Patient safety

MINNEAPOLIS, Sept. 6, 2023 /PRNewswire/ -- VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced today that the company is an early recipient of MDR certification.

Key Points: 
  • MINNEAPOLIS, Sept. 6, 2023 /PRNewswire/ -- VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced today that the company is an early recipient of MDR certification.
  • Gaining MDR certification ensures the FLEX device is in alignment with described requirements and conformity assessment procedures that must be met before medical devices are introduced into the European Economic Area.
  • "CE Mark under these new requirements is more stringent than the CE Mark under the Medical Device Directive and is focused on quality as well as patient safety.
  • "MDR certification demonstrates our commitment to quality and will enable continued commercial expansion of the FLEX Vessel Prep System into the CE marked geographies."

Society for Vascular Surgery Foundation Launches September Vascular Health Step Challenge During PAD Awareness Month & Healthy Aging Month

Retrieved on: 
Friday, September 1, 2023
National Stroke Awareness Month, SVS, Plaque, Risk factor, Obesity, Society, Diabetes, Amputation, Stroke, PAD, Hypoesthesia, Leg, Research, Artery, Society for Vascular Surgery, Pain, Walking, Patient, Risk, Moyamoya disease, Ulcer, Death, Smoking, Conditional sentence, Birth control, Medical device

ROSEMONT, Ill., Sept. 1, 2023 /PRNewswire/ -- The Society for Vascular Surgery (SVS) Foundation today launched its second-annual September Vascular Health Step Challenge to raise awareness about vascular health and promote the benefits of walking for overall well-being, while also raising funds to benefit low-income vascular patients.

Key Points: 
  • ROSEMONT, Ill., Sept. 1, 2023 /PRNewswire/ -- The Society for Vascular Surgery (SVS) Foundation today launched its second-annual September Vascular Health Step Challenge to raise awareness about vascular health and promote the benefits of walking for overall well-being, while also raising funds to benefit low-income vascular patients.
  • The campaign coincides with Peripheral Arterial Disease (PAD) Awareness Month and Healthy Aging Month.
  • "The SVS Foundation invites the community to join our September Vascular Health Step Challenge and quite literally take steps toward better vascular health," says Dr. Joseph Mills, SVS President.
  • "The Vascular Health Step Challenge is not just about walking; it's about advocacy, awareness, and action," says Dr. Michael Dalsing, SVS Foundation Chair.

JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting

Retrieved on: 
Friday, August 18, 2023
Diabetic neuropathy, Extremities, Ohio Society of New York, JAN, Risk, Physician, PAD, Hypoesthesia, CRPS, American Society of Interventional Pain Physicians, LAS, Patient, Security (finance), FDA, Pharmaceutical industry, Pain, Janon

LAS VEGAS, Aug. 18, 2023 /PRNewswire/ -- JanOne (Nasdaq: JAN), a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for underlying causes of pain, will present prior data on Jan101's randomized double blind placebo-controlled trial in diabetic neuropathy patients.

Key Points: 
  • JAN101 Showed Statistically Significant Reduction in Pain and Improvement in Nerve Conduction Velocity in Prior Phase II study.
  • LAS VEGAS, Aug. 18, 2023 /PRNewswire/ -- JanOne (Nasdaq: JAN), a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for underlying causes of pain, will present prior data on Jan101's randomized double blind placebo-controlled trial in diabetic neuropathy patients.
  • The Ohio Society of Interventional Pain Physicians annual meeting is a large regional pain management meeting from August 17 – 20th that draws attendance from physicians across the US.
  • Diabetic neuropathy is an often-debilitating condition that is on the rise in the USA characterized by burning pain and numbness typically in the extremities.

With an FAR of 0, Accura Scan hits the bull's eye for its Face Liveness iBeta Level 2 Certification

Retrieved on: 
Wednesday, August 16, 2023
FAR, DNA, ISO, FRR, ISO/IEC, PAD, 3D, USD, Telecommunications, United Nations Convention on Contracts for the International Sale of Goods, Mask, Account verification, Algorithm, Ambition, Digital, Alpha beta filter, YP, Cryptocurrency, Security printing, EU

Commenting on this feat, Director - International Sales, Reza Writer, added, "Ambition greater than resources is in the DNA of Accura Scan.

Key Points: 
  • Commenting on this feat, Director - International Sales, Reza Writer, added, "Ambition greater than resources is in the DNA of Accura Scan.
  • Passing the evaluation with an FAR of 0%, means that the company's biometric algorithms offer a high level of spoof resistance in all environments.
  • Headquartered in India, Accura Scan has been completely bootstrapped & profitable since its incorporation.
  • With top-notch Identity Verification & Digital KYC products, it is confident of making a mark in these markets.

With an FAR of 0, Accura Scan hits the bull's eye for its Face Liveness iBeta Level 2 Certification

Retrieved on: 
Wednesday, August 16, 2023
FAR, DNA, ISO, FRR, ISO/IEC, PAD, 3D, Multimedia, USD, Telecommunications, United Nations Convention on Contracts for the International Sale of Goods, Mask, Account verification, Algorithm, Ambition, Digital, Alpha beta filter, YP, Cryptocurrency, Security printing, EU

Commenting on this feat, Director - International Sales, Reza Writer, added, "Ambition greater than resources is in the DNA of Accura Scan.

Key Points: 
  • Commenting on this feat, Director - International Sales, Reza Writer, added, "Ambition greater than resources is in the DNA of Accura Scan.
  • The ISO 30107-3 framework measures a biometric system's false acceptance rate (FAR) and false rejection rate (FRR) at the point of presentation.
  • Passing the evaluation with an FAR of 0%, means that the company's biometric algorithms offer a high level of spoof resistance in all environments.
  • Headquartered in India, Accura Scan has been completely bootstrapped & profitable since its incorporation.

Trust Stamp releases a White Paper detailing its newly launched AI-powered suite of facial attributes and quality assessment tools (FAIQA) using an unsupervised machine learning model

Retrieved on: 
Friday, August 11, 2023
Disability-adjusted life year, Tablet, PAD, Trust, IT2, White paper, Movement, Cryptocurrency

Atlanta, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity CompanyTM providing AI-powered trust and identity services used globally across multiple sectors, announces that it has issued a White Paper providing background on its newly launched AI-powered suite of facial attributes and quality assessment tools (FAIQA).

Key Points: 
  • Atlanta, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity CompanyTM providing AI-powered trust and identity services used globally across multiple sectors, announces that it has issued a White Paper providing background on its newly launched AI-powered suite of facial attributes and quality assessment tools (FAIQA).
  • To address these issues, we have built an AI-powered suite of facial attributes and image quality assessment tools (FAIQA) which can be integrated into applications with the objective of improving the quality of the capture.
  • On August 1, 2023, Andrew Gowasack, President of Trust Stamp announced a 31% increase in the Company’s financial services customer base in the prior six-month period.
  • Trust Stamp will release its financial results for the second quarter of 2023, together with an overview of its business performance and strategy on August 14th, 2023.

MCRA Aids Surmodics in Obtaining FDA Pre-Market Approval for Cardiovascular Drug-Coated Balloon

Retrieved on: 
Monday, August 7, 2023
Senior, PAD, MCRA, DCB, Organization, Clinical trial, PMA, Peripheral artery disease, Biocompatibility, Quality assurance, FDA, Health, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Safety, Pharmaceutical industry, Medical device, Computer security

The Surmodics team understood the importance of this collaboration, and we are honored to have played a part in this important PMA approval."

Key Points: 
  • The Surmodics team understood the importance of this collaboration, and we are honored to have played a part in this important PMA approval."
  • For Surmodics, we were able to integrate our biocompatibility expertise with our cardiovascular regulatory experience to create a successful outcome.
  • We thank Surmodics for trusting us to help them achieve their goals for the SurVeil™ drug-coated balloon."
  • Finally, our team enjoyed the spirit of camaraderie and candor in our working relationship with MCRA."

ComplyCube Unveils Enhanced ID Document Security with Advanced Liveness Detection

Retrieved on: 
Monday, August 7, 2023
IDV, 3D, Identity theft, PAD, ML, NFD, ID, Organization, AML, SAN, Machine learning, Safety, IDS, Visage SDK, Killian documents authenticity issues, KYC, Mobile phone, Security printing

Complementing its existing offering of passive (still photos) and active (action based) biometric checks , the ID Liveness Layer uses state-of-the-art Presentation Attack Detection (PAD) technology.

Key Points: 
  • Complementing its existing offering of passive (still photos) and active (action based) biometric checks , the ID Liveness Layer uses state-of-the-art Presentation Attack Detection (PAD) technology.
  • This has positioned us as a trusted liveness detection service provider, heavily depended on by some of the world's biggest organizations," notes Harry Varatharasan, Chief Data Scientist of ComplyCube.
  • Document Liveness Detection is fully integrated into the Document Checking Service .
  • "While some alternative solutions offer selfie-based liveness detection, their effectiveness concerning ID documents leaves much to be desired.

ComplyCube Unveils Enhanced ID Document Security with Advanced Liveness Detection

Retrieved on: 
Monday, August 7, 2023
IDV, Identity theft, PAD, ML, NFD, ID, Organization, AML, SAN, Machine learning, Safety, IDS, Visage SDK, Killian documents authenticity issues, KYC, Mobile phone, Security printing

Complementing its existing offering of passive (still photos) and active (action based) biometric checks , the ID Liveness Layer uses state-of-the-art Presentation Attack Detection (PAD) technology.

Key Points: 
  • Complementing its existing offering of passive (still photos) and active (action based) biometric checks , the ID Liveness Layer uses state-of-the-art Presentation Attack Detection (PAD) technology.
  • This has positioned us as a trusted liveness detection service provider, heavily depended on by some of the world's biggest organizations," notes Harry Varatharasan, Chief Data Scientist of ComplyCube.
  • Document Liveness Detection is fully integrated into the Document Checking Service .
  • "While some alternative solutions offer selfie-based liveness detection, their effectiveness concerning ID documents leaves much to be desired.